发明申请
US20050019308A1 Oncolytic viruses for the treatment of neoplasms having activated PP2A or Rac
审中-公开
用于治疗活化PP2A或Rac的肿瘤的溶瘤病毒
- 专利标题： Oncolytic viruses for the treatment of neoplasms having activated PP2A or Rac
- 专利标题（中）： 用于治疗活化PP2A或Rac的肿瘤的溶瘤病毒
-
申请号： US10886022申请日： 2004-07-06
-
公开(公告)号： US20050019308A1公开(公告)日： 2005-01-27
- 发明人: Kara Norman , Patrick Lee
- 申请人： Kara Norman , Patrick Lee
- 申请人地址： CA Calgary
- 专利权人： Oncolytics Biotech Inc.
- 当前专利权人： Oncolytics Biotech Inc.
- 当前专利权人地址： CA Calgary
- 主分类号： A61K35/76
- IPC分类号： A61K35/76 ; A61K35/765 ; A61K48/00 ; A61P35/00
摘要：
Methods for treating neoplasms, by administering oncolytic viruses to a neoplasm having activated PP2A-like or Rac activities, are disclosed. The virus is administered so that it ultimately directly contacts target cancer cells. Combinations of more than one type and/or strain of oncolytic viruses can be used. Of particular interest is the use of reovirus.
信息查询
